Wealthspire Advisors, LLC Cardiol Therapeutics Inc. Transaction History
Wealthspire Advisors, LLC
- $9.93 Billion
- Q4 2024
A detailed history of Wealthspire Advisors, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 15,151 shares of CRDL stock, worth $19,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,151
Previous 30,302
50.0%
Holding current value
$19,090
Previous $59,000
67.8%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRDL
# of Institutions
46Shares Held
6.79MCall Options Held
5.2KPut Options Held
9.5K-
Tejara Capital LTD London, X03.12MShares$3.93 Million2.61% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.17MShares$1.48 Million0.46% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$1 Million0.31% of portfolio
-
Cambridge Investment Research Advisors, Inc.331KShares$416,4360.0% of portfolio
-
Envestnet Asset Management Inc310KShares$390,2010.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $78M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...